What is Erlotinib 150 mg?
Erlotinib 150 mg is a prescription medication manufactured by Cipla Limited, designed to treat certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors, which target specific proteins involved in cancer cell growth. Erlotinib is primarily used for treating non-small cell lung cancer (NSCLC) and pancreatic cancer.
This medication works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, an enzyme that plays a critical role in the proliferation and survival of cancer cells. By blocking this enzyme, Erlotinib helps to slow down or stop the growth of tumors.
Developed with advanced pharmaceutical technology, Erlotinib 150 mg is the preferred dosage strength for certain treatment regimens. It is widely prescribed in Malaysia and across the globe for adults diagnosed with NSCLC and pancreatic cancer, offering hope for better management of these serious conditions.
Continuous research and clinical trials have demonstrated its effectiveness in improving progression-free survival in patients with EGFR-mutated cancers, making it a valuable option within targeted cancer therapies.
Uses of Erlotinib 150 mg
- Treatment of non-small cell lung cancer (NSCLC)
- Management of advanced or metastatic pancreatic cancer
- Targeted therapy for patients with EGFR mutation-positive tumors
- Used as monotherapy or in combination with other treatments under physician guidance
How Erlotinib 150 mg Works
Erlotinib 150 mg functions by selectively inhibiting the activity of the epidermal growth factor receptor (EGFR) tyrosine kinase enzyme. This receptor is often overexpressed or mutated in certain cancer cells, causing uncontrolled cell division and tumor growth.
By binding to the EGFR, Erlotinib blocks the signaling pathways necessary for cancer cells to grow and multiply. This inhibition thus helps to reduce tumor size and slows the progression of the disease.
The targeted mechanism of Erlotinib limits damage to normal cells compared to traditional chemotherapy, offering a more focused and personalized approach to cancer treatment.
How to take Erlotinib 150 mg
Erlotinib 150 mg should be taken exactly as prescribed by your healthcare provider. Here are some general guidelines:
- Take one tablet daily on an empty stomach, at least one hour before or two hours after meals.
- Swallow the tablet whole with a glass of water; do not crush or chew.
- Consistent daily intake at the same time helps maintain effective drug levels.
- If you miss a dose, take it as soon as you remember; if it is near your next dose, skip the missed one and continue your schedule. Do not double the dose.
- Follow all instructions provided by your doctor, including any monitoring requirements.
Benefits of Erlotinib 150 mg
- Effective targeted therapy for specific cancer types
- Helps slow disease progression and tumor growth
- Oral administration offers convenience over intravenous treatments
- Improved quality of life compared to conventional chemotherapy
- Suitable for patients with EGFR mutation-positive cancers
- Manufactured by Cipla Limited, ensuring high quality and safety standards
Dosage and Administration
The recommended dose of Erlotinib 150 mg is one tablet taken orally once daily. Dosage may be adjusted by your healthcare provider based on your response and tolerability. It is important to follow your physician’s instructions carefully.
Regular monitoring through blood tests and clinical evaluations is necessary during treatment to assess effectiveness and identify any side effects early.
Who Should Use Erlotinib 150 mg?
Erlotinib 150 mg is suitable for adult patients diagnosed with non-small cell lung cancer or pancreatic cancer, especially those with confirmed EGFR mutations. It is prescribed under medical supervision for individuals who require targeted therapy to manage tumor growth.
Who Should Avoid Erlotinib 150 mg?
Patients with a known hypersensitivity to Erlotinib or any of its components should not use Erlotinib 150 mg. It should be avoided in pregnant or breastfeeding women unless recommended by a doctor. Individuals with severe liver or kidney impairment or certain skin conditions should consult their healthcare provider before starting treatment.
Side Effects of Erlotinib 150 mg
- Skin rash or acne-like eruptions
- Diarrhea
- Loss of appetite
- Tiredness or fatigue
- Nausea and vomiting
- Mouth sores
- Dry skin or itching
- Eye irritation or dryness
- Dizziness
- Increased liver enzymes
Safety Advice
- Inform your doctor about any medical conditions before starting Erlotinib.
- Avoid sun exposure and use sunscreen to prevent skin reactions.
- Do not take any new medications, supplements, or herbal products without consulting your healthcare provider.
- Report any severe or persistent side effects immediately.
- Avoid pregnancy during treatment due to potential harm to the fetus.
- Take medication exactly as prescribed; do not alter dosage without medical advice.
Drug Interactions
- May interact with CYP3A4 inducers and inhibitors affecting drug levels.
- Avoid combining with certain anticoagulants unless supervised by a physician.
- Concurrent use with acid-reducing agents can reduce absorption.
- Inform your healthcare provider about all prescription and over-the-counter drugs taken.
Storage Instructions
Store Erlotinib 150 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children. Do not use after the expiration date printed on the package.
Where to buy Erlotinib 150 mg in Malaysia?
Erlotinib 150 mg can be purchased at licensed pharmacies and health care providers throughout Malaysia. It is important to buy from reputable sources to ensure authenticity and quality. Many authorized online pharmacies also offer Erlotinib with proper prescription verification.
Frequently Asked Questions (FAQ)
What is the price of Erlotinib 150 mg in Malaysia?
The price of Erlotinib 150 mg varies depending on the pharmacy and insurance coverage. It is recommended to check with local providers or online authorized pharmacies for current pricing.
What happens if I miss a dose?
If you miss a dose of Erlotinib 150 mg, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.
Where can I find Erlotinib 150 mg for sale?
You can find Erlotinib 150 mg at licensed pharmacies in Malaysia, cancer treatment centers, or trusted online pharmacies that require a valid prescription.
Is Erlotinib 150 mg available in Malaysia?
Yes, Erlotinib 150 mg is available in Malaysia and is commonly prescribed for the treatment of non-small cell lung cancer and pancreatic cancer under medical supervision.
Can Erlotinib 150 mg be taken with other cancer treatments?
Erlotinib may be used alone or combined with other therapies as advised by your oncologist. Always follow the guidance of your healthcare provider regarding combination treatments.
How long does it take to see results with Erlotinib 150 mg?
The effectiveness of Erlotinib can vary; some patients may notice improvements within weeks, while others require longer periods. Regular monitoring by your doctor is essential to evaluate treatment response.
Are there any dietary restrictions while taking Erlotinib 150 mg?
Take Erlotinib on an empty stomach to ensure proper absorption. Avoid acidic foods or beverages near dosing times, and discuss any dietary concerns with your healthcare provider.
Conclusion
Erlotinib 150 mg is a bolt targeted therapy offering a specialized approach for managing non-small cell lung cancer and pancreatic cancer. Manufactured by Cipla Limited, it provides patients in Malaysia with an effective treatment option aimed at improving disease control while maintaining quality of life. By understanding its use, administration, and safety profile, patients can engage confidently in their cancer treatment journey alongside their healthcare team.
Leave A Review